Congenital cytomegalovirus infection: features of the clinical course and catamnesis according to own observations

Congenital cytomegalovirus infection is the most common congenital infection, occurs in 0.6-5% of newborns worldwide, and is considered the leading non-genetic cause of sensorineural hearing loss in children. Most newborns with a manifest form of the disease develop psychomotor and cognitive disorders, and about half of them develop visual impairment.

The purpose of publication: to present a clinical case of severe congenital cytomegalovirus infection in the manifest period with multisystem manifestations (hemorrhagic syndrome, encephalitis, myocarditis, hepatitis, splenomegaly) and follow-up data at the age of 1 year.

Conclusion. this clinical example demonstrates diagnostic and therapeutic difficulties in the acute period of the disease and a significant list of diseases resulting from infection. Based on the information presented, the importance and necessity of close attention to the results of a serological study of pregnant women during the entire gestation period with an assessment of the antibody titer to cytomegalovirus infection in dynamics are updated. Specific antiviral therapy, prescribed on the basis of a life-threatening course of a severe manifest form of the disease, made it possible to achieve positive dynamics in the acute period, eradicate the virus and prevent severe outcomes, including death.

1. Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017;43(1):38. doi:10.1186/s13052-017-0358-8.

2. Jenks CM, Hoff SR, Mithal LB. Congenital Cytomegalovirus Infection: Epidemiology, Timely Diagnosis, and Management. Neoreviews. 2021;22(9):e606-e613. doi: 10.1542/neo.22-9-e606. PMID: 34470762.

3. Tol I, Heath PT, Khalil A. Prevention strategies for congenital cytomegalovirus infection. Curr Opin Infect Dis. 2021;34(5):546-551. doi: 10.1097/QCO.0000000000000777. PMID: 34334662.

4. Ross SA, Kimberlin D. Clinical outcome and the role of antivirals in congenital cytomegalovirus infection. Antiviral Res. 2021;191:105083. doi: 10.1016/j.antiviral.2021.105083. Epub 2021 May 5. PMID: 33964331.

5. Palma S, Roversi MF, Bettini M, Mazzoni S, Pietrosemoli P, Lucaccioni L, Berardi A, Genovese E. Hearing loss in children with congenital cytomegalovirus infection: an 11-year retrospective study based on laboratory database of a tertiary paediatric hospital. Acta Otorhinolaryngol Ital. 2019;39(1):40-45. doi: 10.14639/0392-100X-2020. PMID: 30936577; PMCID: PMC6444162.

6. Foulon I, De Brucker Y, Buyl R, Lichtert E, Verbruggen K, Piérard D, Camfferman FA, Gucciardo L, Gordts F. Hearing Loss With Congenital Cytomegalovirus Infection. Pediatrics. 2019;144(2):e20183095. doi: 10.1542/peds.2018-3095. PMID: 31266824.

7. Giannattasio A, Di Costanzo P, De Matteis A, Milite P, De Martino D, Bucci L, Augurio MR, Bravaccio C, Ferrara T, Capasso L, Raimondi F. Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection. J Clin Virol. 2017;96:32-36. doi: 10.1016/j.jcv.2017.09.006. PMID: 28938230.

8. Thigpen J. Congenital Cytomegalovirus-History, Current Practice, and Future Opportunities. Neonatal Netw. 2020;39(5):293-298. doi: 10.1891/0730-0832.39.5.293. PMID: 32879045.

9. Nicloux M, Peterman L, Parodi M, Magny JF. Outcome and management of newborns with congenital cytomegalovirus infection. Arch Pediatr. 2020;27(3):160-165. doi: 10.1016/j.arcped.2020.01.006. PMID: 32127242.

10. Lim Y, Lyall H. Congenital cytomegalovirus - who, when, what-with and why to treat? J Infect. 2017;74 Suppl 1:S89-S94. doi: 10.1016/S0163-4453(17)30197-4. PMID: 28646968.

11. Chiopris G, Veronese P, Cusenza F, et al. Congenital Cytomegalovirus Infection: Update on Diagnosis and Treatment. Microorganisms. 2020;8(10):1516. doi:10.3390/microorganisms8101516.

12. Klinicheskie rekomendacii [proekt] Vrozhdennaya citomegalovirusnaya infekciya / Balashova E.N. [i dr.]. – b/i, 2019. – 49. http://www.raspm.ru/files/CMVI1.pdf

13. Xia W, Yan H, Zhang Y, et al. Congenital Human Cytomegalovirus Infection Inducing Sensorineural Hearing Loss. Front Microbiol. 2021;12:649690. doi:10.3389/fmicb.2021.649690.

14. Morioka I, Kakei Y, Omori T, Nozu K, Fujioka K, Yoshikawa T, Moriuchi H, Ito Y, Oka A. Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: Study Protocol Clinical Trial (SPIRIT Compliant). Medicine (Baltimore). 2020;99(17):e19765. doi: 10.1097/MD.0000000000019765. PMID: 32332615; PMCID: PMC7220768).